Oncologist

1st Clinic of Oncology

Experience

  • July 2020 till present Medical Oncologist in 4th Medical Oncology Department at the Henry Dunant Hospital Center, Athens, Greece.
  • December 2020 till December 2021 Clinical Research Fellow in ATTIKON University Hospital, Athens, Greece.
  • October 2019 till June 2020 Consultant in Medical Oncology Department at the Metaxa Memorial Cancer Hospital of Athens, Piraeus.

Speciality

  • 1999-2005: Graduate of the Medical School of the University of Alexandria, Egypt.
  • 2005 – 2006: House officer at the University Hospital of Alexandria, Egypt.
  • 2006-2007 House officer in Internal Medicine Department of various Clinics in Alexandria, Egypt.
  • 2007 - 2008 Recognition of the DOATAP degree.
  • 2009-2010 Military service:

     - 2nd Internal Medicine Department - 401 Military Hospital, Athens, Greece.

      - Kos Island Health Military Center.

  • March - October 2010 House Officer in the NGO "Medical Intervention".
  • November 2010 – May 2012 Doctor / Researcher at the 3rd Oncology Clinic of "Hygeia" - Hellenic Collaborative Oncology Group, Athens.
  • June 2012 till June 2015 Resident of Internal Medicine and Hematology in the 4th Internal Medicine Department and in the Hematology Department of Evangelismos Hospital, Athens.
  • November 2015 till August 2016 Resident in Medical Oncology Department at the University Hospital of Ioannina (training position).
  • March 2017 till 10/11/2019 Resident in Medical Oncology Department at the Metaxa Memorial Cancer Hospital of Athens, Piraeus.
  • Gynecological malignancies, breast cancer, clinical and translational research, gastrointestinal cancer, lung cancer, head & neck cancer.

Retraining

  • 2014 – 2016 Postgraduate studies at the School of Medicine of the University of Athens "Neoplastic Disease in Man - Modern Clinicopathological Approach and Research". Master Degree.
  • 28th September 2019: Successfully passed the ESMO examination held in Barcelona, Spain.
  • October 2021: Successfully passed the ESGO examination held in Prague, Czech Republic.
  • Regular participation at seminars and conferences on medical oncology.

Recognitions & Awards

  • 3rd Hellenic Conference of Medical Oncology, Ioannina, April 21-23, 2016
  • 2nd Best Presentation Award
  • 5th Hellenic Conference of Medical Oncology, Athens, July 9-11, 2020:

Publications

  1. Ischemic Stroke as the First Manifestation of Hepatic Epithelioid Hemangioendothelioma

Zis Panagiotis, Avraam Assi, Dimitrios Kravaritis, Vassilios A. Sevastianos.

Journal of Stroke and Cerebrovascular Diseases , Volume 23 , Issue 3 , e237 - e240

 

  1. IT-019. MGMT METHYLATION, BRAF AND IDH1/2 MUTATIONS AND EGFR VARIANT III DETECTION AND THEIR ASSOCIATION WITH BEVACIZUMAB TREATMENT

Georgios Rigakos, Olympia Spyri, Pau Nomikos, Flora Stavridi, Irene Grossi, Ioanna Theodorakopoulou, Avraam Assi, Georgios Kouvatseas, Eirini Papadopoulou, Georgios Nasioulas, Stefanos Labropoulos, and Evangelia Razis. Neuro Oncol. 2013 November; 15(Suppl 3): iii68–iii74.

  1. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review

Boussios, Stergios, Esmeralda Seraj, George Zarkavelis, Dimitrios Petrakis, Aristomenes Kollas, Aikaterini Kafantari, Abraam Assi, Konstantina Tatsi, Nicholas Pavlidis, George Pentheroudakis.

Critical Reviews in Oncology / Hematology , Volume 108 , 164 – 174

 

  1. Razis, Evangelia, Avraam Assi, Albert Huang, Georgios Rigakos, Sotirios Papadopoulos, Savvas Papadopoulos, Constantinos Dardoufas, Christos N. Mourmouris, Stefanos Lampropoulos and Panagiotis Nomikos. “Extracranial and Diffuse Bone Marrow Metastases from Anaplastic Oligodendroglioma : A Case Report and Review of the Literature.” J Clin Case Rep Trials Volume 2: 1 (2019).

 

  1. Fergadis, Evangelos & Assi, Abraam & Kranidioti, Eleftheria & Kosma, Aikaterini & Karakosta, Maria & Miltiadou, Konstantinos & Dimitriadis, Georgios & Grivas, Anastasios & Lianos, Evangelos & Athanassopoulos, Angelos & Kosmas, Christos. (2020). Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant. Clinical Lymphoma, Myeloma and Leukemia. 20. e50-e57. 10.1016/j.clml.2019.11.022.

 

  1. Levva Sofia, Skolariki Aglaia, Sogka Eleni, Bokas Alexandros, Assi Avraam, Pispirigou Marianna K. and Koliou Panagiotis. "The evolving role of PARP inhibitors in advanced ovarian cancer" Forum of Clinical Oncology, vol.12, no.1, 2021, pp.82-104.

See in same sector